Impact of peritoneal metastasis on overall survival in patients with advanced endometrial cancer receiving lenvatinib plus pembrolizumab.

Discov Oncol · 2026 · PMC13103040 · PMID 41832914

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

showed a trendp = 0.087so close (0.05 < p ≤ 0.1)

Additionally, patients aged ≥ 75 years showed a trend toward shorter PFS ( p = 0.087).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.